Navigation Links
WuXi PharmaTech Schedules Third-Quarter 2009 Earnings Release

SHANGHAI, Oct. 28 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 2009 after the New York Stock Exchange closes on Monday, November 16, 2009 (which will be Tuesday morning, November 17, 2009 Shanghai time).

(Logo: )

The earnings release will be available on the investor relations section of its website at .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, November 17, 2009, to discuss the third-quarter 2009 financial results and recent business activities. The conference call may be accessed by calling:

        United States:    1-866-519-4004
        China (Landline): 800-819-0121
        China (Mobile):   400-620-8038
        Hong Kong:        800-930-346
        United Kingdom:   0-808-234-6646
        International:    +65-6735-7955
        Conference ID:    38748238

    A telephone replay will be available two hours after the call's completion

        United States:    1-866-214-5335
        China North:      10-800-714-0386
        China South:      10-800-140-0386
        Hong Kong:        800-901-596
        United Kingdom:   0-800-731-7846
        International:    +61-2-8235-5000
        Conference ID:    38748238

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: .

    For more information, please contact:

     Ronald Aldridge
     Director of Investor Relations
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-201-585-2048


SOURCE WuXi PharmaTech (Cayman) Inc.

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi PharmaTech to Participate in Upcoming Investor Conferences
2. WuXi PharmaTech Selected as One of the Top Ten Employer for New College Graduates in Pharmaceutical Industry in 2009
3. WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
4. WuXi PharmaTech Files 2008 Annual Report on Form 20-F
5. WuXi PharmaTech Announces First-Quarter 2009 Results
6. WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
7. Pharmatech Oncology Launches New Data Management Business Unit
8. WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
9. WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
10. WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year
11. WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... optimization of adjunctive imaging is the focus of numerous abstracts accepted for presentation ... 29-December 4, 2015. Nine abstracts highlight the use of Volpara Solutions’ quantitative ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December ... the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis ... celebrates exceptional special needs providers that excel in synthesizing the areas of clinical ...
(Date:12/1/2015)... ... December 01, 2015 , ... TCS Healthcare Technologies (TCS), a ... health arenas, is pleased to announce that VIP Care Services, a Caprock Health ... the ACUITY Complete Care™ Management to back their collaborative catastrophic case management initiatives. ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , users ... over customization, the possibilities are truly endless, all with a click of a mouse. ... vertical flip, horizontal flip, depth of field and more, all within Final Cut Pro ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced today ... status from Cisco. This designation recognizes Tympani as having fulfilled the training requirements ... targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President of ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... and TELTOW, Germany , ... Instruments (SMI) , a leading global manufacturer of eye ... LLC has included SMI remote eye trackers as ... help healthcare providers assess concussions, eye sight, and medical ... RED -oem technology is part of SMI,s mass-market-ready eye ...
(Date:12/1/2015)... , December 1, 2015 ... Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), among ... has acquired Elekta,s Leksell Gamma Knife® Icon™, the ... brain. --> --> ... or traditional frame-based treatments, Leksell Gamma Knife Icon ...
(Date:12/1/2015)... 01, 2015 ... "Drug Delivery Technology Market 2015 - Forecast to ... ) has announced the addition of ... Forecast to 2020" report to their offering. ... ) has announced the addition of the ...
Breaking Medicine Technology: